JP2023510019A5 - - Google Patents
Info
- Publication number
- JP2023510019A5 JP2023510019A5 JP2022542986A JP2022542986A JP2023510019A5 JP 2023510019 A5 JP2023510019 A5 JP 2023510019A5 JP 2022542986 A JP2022542986 A JP 2022542986A JP 2022542986 A JP2022542986 A JP 2022542986A JP 2023510019 A5 JP2023510019 A5 JP 2023510019A5
- Authority
- JP
- Japan
- Prior art keywords
- isolated peptide
- group
- peptide according
- proline
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL272074A IL272074B2 (en) | 2020-01-15 | 2020-01-15 | Peptide compounds and methods of treating diseases using same |
| IL272074 | 2020-01-15 | ||
| PCT/IL2021/050044 WO2021144798A1 (en) | 2020-01-15 | 2021-01-14 | Peptide compounds and methods of treating diseases using same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023510019A JP2023510019A (ja) | 2023-03-10 |
| JP2023510019A5 true JP2023510019A5 (enExample) | 2024-01-19 |
| JP7809060B2 JP7809060B2 (ja) | 2026-01-30 |
Family
ID=76863930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022542986A Active JP7809060B2 (ja) | 2020-01-15 | 2021-01-14 | ペプチド化合物およびそれを用いる疾患の治療方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230049549A1 (enExample) |
| EP (1) | EP4090347A1 (enExample) |
| JP (1) | JP7809060B2 (enExample) |
| KR (1) | KR20220145826A (enExample) |
| CN (6) | CN119708144A (enExample) |
| AU (1) | AU2021207415A1 (enExample) |
| BR (1) | BR112022013978A2 (enExample) |
| CA (1) | CA3167139A1 (enExample) |
| CO (1) | CO2022011101A2 (enExample) |
| IL (1) | IL272074B2 (enExample) |
| MX (1) | MX2022008746A (enExample) |
| WO (1) | WO2021144798A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL280101B2 (en) | 2018-07-11 | 2025-05-01 | Immunity Pharma Ltd | Peptide compounds and their therapeutic uses |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154600B (nl) | 1971-02-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen. |
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| NL154599B (nl) | 1970-12-28 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking. |
| US3901654A (en) | 1971-06-21 | 1975-08-26 | Biological Developments | Receptor assays of biologically active compounds employing biologically specific receptors |
| US3853987A (en) | 1971-09-01 | 1974-12-10 | W Dreyer | Immunological reagent and radioimmuno assay |
| US3867517A (en) | 1971-12-21 | 1975-02-18 | Abbott Lab | Direct radioimmunoassay for antigens and their antibodies |
| NL171930C (nl) | 1972-05-11 | 1983-06-01 | Akzo Nv | Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen. |
| US3850578A (en) | 1973-03-12 | 1974-11-26 | H Mcconnell | Process for assaying for biologically active molecules |
| US3935074A (en) | 1973-12-17 | 1976-01-27 | Syva Company | Antibody steric hindrance immunoassay with two antibodies |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4034074A (en) | 1974-09-19 | 1977-07-05 | The Board Of Trustees Of Leland Stanford Junior University | Universal reagent 2-site immunoradiometric assay using labelled anti (IgG) |
| US3984533A (en) | 1975-11-13 | 1976-10-05 | General Electric Company | Electrophoretic method of detecting antigen-antibody reaction |
| US4098876A (en) | 1976-10-26 | 1978-07-04 | Corning Glass Works | Reverse sandwich immunoassay |
| US4879219A (en) | 1980-09-19 | 1989-11-07 | General Hospital Corporation | Immunoassay utilizing monoclonal high affinity IgM antibodies |
| US5011771A (en) | 1984-04-12 | 1991-04-30 | The General Hospital Corporation | Multiepitopic immunometric assay |
| US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
| US5272057A (en) | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
| US5192659A (en) | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
| US5281521A (en) | 1992-07-20 | 1994-01-25 | The Trustees Of The University Of Pennsylvania | Modified avidin-biotin technique |
| EP0928968A1 (en) | 1998-01-12 | 1999-07-14 | Universität Basel | Screening method for apoptosis and necrosis |
| CA2443314C (en) | 2001-04-03 | 2006-03-21 | The Board Of Trustees Of The Leland Stanford Junior University | Method of imaging cell death in vivo |
| WO2003037172A2 (en) * | 2001-11-01 | 2003-05-08 | Gpc Biotech Inc. | Endothelial-cell binding peptides for diagnosis and therapy |
| AU2005276117C1 (en) * | 2004-08-23 | 2013-04-18 | Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science | Peptide inhibitors for mediating stress responses |
| US8648045B2 (en) * | 2005-03-10 | 2014-02-11 | Ben Gurion University Of The Negev Research And Development Authority Ltd. | VDAC1 compositions and methods of use thereof for regulating apoptosis |
| CA2737924A1 (en) * | 2008-10-06 | 2010-04-15 | Joshua Robert Schultz | Methods of treating inflammation |
| US20130096070A1 (en) * | 2009-04-07 | 2013-04-18 | University Of Kansas | Peptide targeting of inner ear cells |
| CA2836503C (en) * | 2011-05-23 | 2020-09-22 | Yeda Research And Development Co. Ltd. | Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same |
| BR112017022845A2 (pt) * | 2015-04-23 | 2018-07-17 | Nantomics, Llc | neoepítopos de câncer |
| IL280101B2 (en) * | 2018-07-11 | 2025-05-01 | Immunity Pharma Ltd | Peptide compounds and their therapeutic uses |
-
2020
- 2020-01-15 IL IL272074A patent/IL272074B2/en unknown
-
2021
- 2021-01-14 US US17/792,787 patent/US20230049549A1/en active Pending
- 2021-01-14 EP EP21704023.7A patent/EP4090347A1/en active Pending
- 2021-01-14 CN CN202411888874.5A patent/CN119708144A/zh active Pending
- 2021-01-14 KR KR1020227028077A patent/KR20220145826A/ko active Pending
- 2021-01-14 JP JP2022542986A patent/JP7809060B2/ja active Active
- 2021-01-14 CN CN202411888865.6A patent/CN119708140A/zh active Pending
- 2021-01-14 CN CN202411888870.7A patent/CN119708142A/zh active Pending
- 2021-01-14 CN CN202411888869.4A patent/CN119708141A/zh active Pending
- 2021-01-14 CA CA3167139A patent/CA3167139A1/en active Pending
- 2021-01-14 CN CN202411888873.0A patent/CN119708143A/zh active Pending
- 2021-01-14 CN CN202180017719.4A patent/CN115942948B/zh active Active
- 2021-01-14 AU AU2021207415A patent/AU2021207415A1/en active Pending
- 2021-01-14 MX MX2022008746A patent/MX2022008746A/es unknown
- 2021-01-14 BR BR112022013978A patent/BR112022013978A2/pt unknown
- 2021-01-14 WO PCT/IL2021/050044 patent/WO2021144798A1/en not_active Ceased
-
2022
- 2022-08-04 CO CONC2022/0011101A patent/CO2022011101A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1038841C (zh) | 新型多肽以及由其制备的抗人类免疫缺陷病毒制剂 | |
| US5229489A (en) | Parathyroid hormone antagonists | |
| HU176623B (en) | Process for producing new polypeptides of calcitanine-type | |
| SK11242002A3 (sk) | Zlúčenina, spôsob prípravy zlúčeniny, farmaceutický prostriedok a spôsob liečenia rakoviny | |
| JP2023510019A5 (enExample) | ||
| JP2017523957A (ja) | Ｄ−アルギニル−２，６−ジメチル−ｌ−チロシル−ｌ−リシル−ｌ−フェニルアラニンアミドの製造方法 | |
| JP4933708B2 (ja) | 骨形成作用を有する新規なペプチドおよびこれを固定化してなる骨形成促進剤 | |
| KERTSCHER et al. | Spontaneous chemical degradation of substance P in the solid phase and in solution | |
| SK284550B6 (sk) | Peptidy, farmaceutický prostriedok s ich obsahom a ich použitie | |
| US5624900A (en) | Peptide or its salts | |
| JP2012508728A (ja) | 特定のリガンドを含むアフィニティー樹脂を使用する、ヒト成長ホルモンポリペプチドの精製方法 | |
| EP0640618B1 (de) | Tetrahydronaphthalin-Peptidderivate | |
| EP0339193B1 (en) | Peptide ligands for bombesin receptors | |
| US11384119B2 (en) | Compositions and methods for inhibiting CD279 interactions | |
| JP2021531246A5 (enExample) | ||
| AU718320B2 (en) | Peptide derivatives | |
| JPH0625288A (ja) | ペプチドまたはその塩 | |
| CN102596894B (zh) | 2-氨基-3-甲基-己-5-烯酸及其在制备肽如杆菌肽中的应用 | |
| JP2009503092A5 (enExample) | ||
| RU2024102163A (ru) | Пептидные соединения и их терапевтическое применение | |
| EP1337551B1 (en) | Substance p analogs for the treatment of cancer | |
| US5252705A (en) | Peptide derivatives | |
| JP2967956B2 (ja) | ペプチドまたはその塩 | |
| NL8400965A (nl) | Gonadoliberinederivaten met een beta-aspartylgroep, werkwijze voor de bereiding ervan en farmaceutische preparaten met dergelijke derivaten erin. | |
| JP2005126360A (ja) | 新規なポリペプチドで構成されたコラゲナーゼ阻害剤 |